vs

Side-by-side financial comparison of COASTAL FINANCIAL CORP (CCB) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

COASTAL FINANCIAL CORP is the larger business by last-quarter revenue ($138.0M vs $83.1M, roughly 1.7× PROCEPT BioRobotics Corp). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -5.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -3.6%).

Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CCB vs PRCT — Head-to-Head

Bigger by revenue
CCB
CCB
1.7× larger
CCB
$138.0M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+26.0% gap
PRCT
20.2%
-5.8%
CCB
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-3.6%
CCB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CCB
CCB
PRCT
PRCT
Revenue
$138.0M
$83.1M
Net Profit
$-31.6M
Gross Margin
64.9%
Operating Margin
12.4%
-4.1%
Net Margin
-38.1%
Revenue YoY
-5.8%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$0.84
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCB
CCB
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$138.0M
$76.4M
Q3 25
$144.7M
$83.3M
Q2 25
$119.4M
$79.2M
Q1 25
$139.5M
$69.2M
Q4 24
$146.5M
$68.2M
Q3 24
$151.1M
$58.4M
Q2 24
$135.3M
$53.4M
Net Profit
CCB
CCB
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$13.6M
$-21.4M
Q2 25
$11.0M
$-19.6M
Q1 25
$9.7M
$-24.7M
Q4 24
$-18.9M
Q3 24
$13.5M
$-21.0M
Q2 24
$11.6M
$-25.6M
Gross Margin
CCB
CCB
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
CCB
CCB
PRCT
PRCT
Q1 26
-4.1%
Q4 25
12.4%
-40.6%
Q3 25
12.4%
-27.8%
Q2 25
12.0%
-28.0%
Q1 25
8.4%
-39.7%
Q4 24
11.7%
-28.9%
Q3 24
10.8%
-38.4%
Q2 24
11.1%
-50.3%
Net Margin
CCB
CCB
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
9.4%
-25.7%
Q2 25
9.2%
-24.7%
Q1 25
7.0%
-35.8%
Q4 24
-27.6%
Q3 24
8.9%
-35.9%
Q2 24
8.6%
-48.0%
EPS (diluted)
CCB
CCB
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.84
$-0.54
Q3 25
$0.88
$-0.38
Q2 25
$0.71
$-0.35
Q1 25
$0.63
$-0.45
Q4 24
$0.95
$-0.34
Q3 24
$0.97
$-0.40
Q2 24
$0.84
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCB
CCB
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$491.0M
$347.7M
Total Assets
$4.7B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCB
CCB
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
CCB
CCB
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
CCB
CCB
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$491.0M
$365.9M
Q3 25
$475.3M
$380.3M
Q2 25
$461.7M
$385.8M
Q1 25
$449.9M
$389.2M
Q4 24
$438.7M
$402.2M
Q3 24
$331.9M
$241.2M
Q2 24
$316.7M
$251.8M
Total Assets
CCB
CCB
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$4.7B
$508.1M
Q3 25
$4.6B
$511.5M
Q2 25
$4.5B
$513.1M
Q1 25
$4.3B
$519.4M
Q4 24
$4.1B
$534.0M
Q3 24
$4.1B
$374.1M
Q2 24
$4.0B
$374.4M
Debt / Equity
CCB
CCB
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCB
CCB
PRCT
PRCT
Operating Cash FlowLast quarter
$254.6M
Free Cash FlowOCF − Capex
$246.1M
FCF MarginFCF / Revenue
178.3%
Capex IntensityCapex / Revenue
6.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$436.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCB
CCB
PRCT
PRCT
Q1 26
Q4 25
$254.6M
$-10.3M
Q3 25
$59.0M
$-6.6M
Q2 25
$66.0M
$-15.0M
Q1 25
$71.7M
$-17.0M
Q4 24
$259.8M
$-32.4M
Q3 24
$62.6M
$-18.8M
Q2 24
$72.1M
$-15.7M
Free Cash Flow
CCB
CCB
PRCT
PRCT
Q1 26
Q4 25
$246.1M
$-12.2M
Q3 25
$57.4M
$-9.5M
Q2 25
$64.0M
$-17.8M
Q1 25
$68.9M
$-18.8M
Q4 24
$249.9M
$-33.6M
Q3 24
$60.2M
$-19.0M
Q2 24
$69.5M
$-16.8M
FCF Margin
CCB
CCB
PRCT
PRCT
Q1 26
Q4 25
178.3%
-15.9%
Q3 25
39.7%
-11.4%
Q2 25
53.6%
-22.5%
Q1 25
49.4%
-27.2%
Q4 24
170.6%
-49.2%
Q3 24
39.8%
-32.6%
Q2 24
51.3%
-31.4%
Capex Intensity
CCB
CCB
PRCT
PRCT
Q1 26
Q4 25
6.1%
2.4%
Q3 25
1.2%
3.4%
Q2 25
1.7%
3.5%
Q1 25
2.0%
2.7%
Q4 24
6.8%
1.7%
Q3 24
1.6%
0.4%
Q2 24
1.9%
2.0%
Cash Conversion
CCB
CCB
PRCT
PRCT
Q1 26
Q4 25
Q3 25
4.34×
Q2 25
5.99×
Q1 25
7.37×
Q4 24
Q3 24
4.65×
Q2 24
6.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCB
CCB

Other$74.7M54%
Baa S Credit Enhancements$47.3M34%
Baa S Program Income$8.4M6%
Transaction Fees$4.9M4%
Servicing And Other Baa S Fees$1.6M1%
Baa S Fraud Enhancements$1.1M1%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons